RxDoctor Payments Data

Richard Krauss, MD

Gynecology · Philadelphia, PANPI 1124056395

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.4% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 72.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $460 and has fallen 91.3% since, to $40 in 2025.

$923in general payments, 2019–2025

Across 37 payments — averaging $24.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$668
  • AMAG Pharmaceuticals, Inc.$72
  • Coopersurgical, Inc.$63
  • Medtronic$48
  • Hologic Sales And Service, LLC$27
  • Sanofi Pasteur Inc.$26
  • plus $19 from 1 others

What the payments were for

  • Food & beverage$84391%
  • Education$799%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$923 in reported general payments places this provider in the 60th percentile of 98 gynecology providers in Pennsylvania.

See all gynecology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,883
Medicare patients
112
Services billed
182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol86$7,134
PremarinEstrogens, Conjugated11$6,391
YuvafemEstradiol19$4,480
Estradiol (Twice Weekly)Estradiol13$2,497
ValacyclovirValacyclovir Hcl26$912
Raloxifene Hcl11$642
Risedronate Sodium15$606
Alendronate Sodium43$328
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip16$310
Fluconazole14$52

Paid to pharmacies, not to this prescriber.

Other gynecology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →